TB Alliance Statement on EMA Approval of Fexinidazole
November 19, 2018 – NEW YORK – TB Alliance congratulates DNDi and its partners on receiving a positive scientific opinion of […]
News
TB Alliance Joins Innovative Medicines Initiative to Accelerate Development of New TB Cures
[October 24, 2018, NEW YORK] – TB Alliance has joined the Innovative Medicines Initiative (IMI) as an Associated Partner on
Statement on UN High-Level Meeting on TB
NEW YORK (September 26, 2018) It has been 25 years since tuberculosis (TB) was declared a global emergency by the World
TB Alliance and Liverpool School of Tropical Medicine Collaborate to Develop New TB Therapies
LIVERPOOL (September 19, 2018) – The Liverpool School of Tropical Medicine (LSTM) and TB Alliance are collaborating to investigate novel
Once Again, New TB Numbers Underscore the Need for New Treatments
Tuberculosis (TB) is still the world’s deadliest infectious disease, as reported today by the World Health Organization (WHO). Last year
SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia
NEW YORK, NY (August 28, 2018)—TB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether
TB Alliance Statement on WHO Rapid Communication Regarding MDR-TB Treatment
TB Alliance congratulates the World Health Organization on the issuance of its rapid communication informing all stakeholders about the key
TB Alliance Names Angela Vanderploeg as Chief Financial Officer
NEW YORK (July 13, 2018) – TB Alliance today announced the appointment of Angela Vanderploeg as Chief Financial Officer. Ms.
News
In Memory of Professor Denis Mitchison
It was with great sadness that we received the news of Professor Denis Mitchison’s passing at the age of 98
Statement on Civil Society Hearing on the UN High Level Meeting on Tuberculosis
On 4 June 2018, TB Alliance participated in the Interactive Civil Society Hearing as part of the preparatory process towards